Literature DB >> 8373784

Kinetic characterization of reductively methylated myosin subfragment 1.

H D White1, I Rayment.   

Abstract

Reductive methylation of myosin-S1 converts 97% of lysine residues in native myosin-S1 to dimethyllysine without detectable modification of other amino acid side chains. RM-S1 is catalytically active, although the rate and equilibrium constants of many of the steps of the actomyosin ATP hydrolysis mechanism have been altered. The steady-state rate of MgATP hydrolysis by modified myosin-S1 (RM-S1) is increased 4-5-fold in the absence of actin. However, the maximum steady-state rate of RM-S1 at saturating actin, 0.59 s-1, is less than one-tenth that observed for the unmodified protein, 7.4 s-1 (5 mM MOPS, 2 mM MgCl2, pH 7, 20 degrees C). Under single-turnover conditions [S1] > [ATP], the observed rate of ATP hydrolysis by RM-S1 is fit by a single exponential that is no more than twice the steady-state rate, which indicates that the bond splitting state is at least partially rate limiting for RM-S1. Although a small decrease in intrinsic tryptophan fluorescence is observed upon ATP binding to RM-acto-S1, the large and rapid fluorescence enhancement produced by aza-ATP binding to RM-acto-S1 is nearly normal. ATP binds and dissociates modified RM-S1 from actin with a second-order rate constant that is more than twice that observed for control S1. The changes in the kinetic mechanism produced by reductive methylation of lysine are qualitatively and quantitatively similar to the changes that are induced by either SH1 modification or substrate analogues such as GTP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373784     DOI: 10.1021/bi00088a042

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  The structural basis of muscle contraction.

Authors:  K C Holmes; M A Geeves
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-04-29       Impact factor: 6.237

2.  The myosin inhibitor blebbistatin stabilizes the super-relaxed state in skeletal muscle.

Authors:  Clyde Wilson; Nariman Naber; Edward Pate; Roger Cooke
Journal:  Biophys J       Date:  2014-10-07       Impact factor: 4.033

3.  Differential scanning calorimetric study of the complexes of modified myosin subfragment 1 with ADP and vanadate or beryllium fluoride.

Authors:  N L Golitsina; A A Bobkov; I V Dedova; D A Pavlov; O P Nikolaeva; V N Orlov; D I Levitsky
Journal:  J Muscle Res Cell Motil       Date:  1996-08       Impact factor: 2.698

4.  Subfragment 1: the first crystalline motor.

Authors:  R G Yount
Journal:  J Muscle Res Cell Motil       Date:  1993-12       Impact factor: 2.698

5.  Structural characterization of the binding of Myosin*ADP*Pi to actin in permeabilized rabbit psoas muscle.

Authors:  Sengen Xu; Jin Gu; Betty Belknap; Howard White; Leepo C Yu
Journal:  Biophys J       Date:  2006-08-11       Impact factor: 4.033

6.  Kinetic and equilibrium analysis of the myosin ATPase.

Authors:  Enrique M De La Cruz; E Michael Ostap
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

7.  Lysine methylation strategies for characterizing protein conformations by NMR.

Authors:  Sacha Thierry Larda; Michael P Bokoch; Ferenc Evanics; R Scott Prosser
Journal:  J Biomol NMR       Date:  2012-09-08       Impact factor: 2.835

8.  Stimulation of in vitro sumoylation by Slx5-Slx8: evidence for a functional interaction with the SUMO pathway.

Authors:  Tatsuya Ii; Janet R Mullen; Christopher E Slagle; Steven J Brill
Journal:  DNA Repair (Amst)       Date:  2007-07-31

9.  Effect of lysine methylation and other ATPase modulators on the active site of myosin subfragment 1.

Authors:  D B Bivin; K Ue; M Khoroshev; M Morales
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

10.  The radius of gyration of native and reductively methylated myosin subfragment-1 from neutron scattering.

Authors:  D B Stone; D K Schneider; Z Huang; R A Mendelson
Journal:  Biophys J       Date:  1995-09       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.